Rafferty Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$632K Sell
12,092
-4,684
-28% -$281K ﹤0.01% 861
2025
Q4
$987K Sell
16,776
-6,274
-27% -$381K ﹤0.01% 801
2025
Q3
$1.28M Buy
23,050
+6,480
+39% +$347K ﹤0.01% 742
2025
Q2
$853K Buy
16,570
+1,932
+13% +$97.1K ﹤0.01% 790
2025
Q1
$858K Sell
14,638
-5,894
-29% -$399K ﹤0.01% 774
2024
Q4
$1.48M Buy
20,532
+4,548
+28% +$334K 0.01% 718
2024
Q3
$1.28M Sell
15,984
-1,149
-7% -$86.3K ﹤0.01% 747
2024
Q2
$1.23M Buy
17,133
+920
+6% +$67.7K ﹤0.01% 767
2024
Q1
$1.14M Buy
16,213
+115
+0.7% +$8.23K ﹤0.01% 809
2023
Q4
$1.24M Sell
16,098
-328
-2% -$21.6K 0.01% 790
2023
Q3
$1.12M Buy
16,426
+1,145
+7% +$90.5K 0.01% 767
2023
Q2
$1.25M Buy
15,281
+1,191
+8% +$95.7K 0.01% 763
2023
Q1
$1.05M Buy
14,090
+592
+4% +$45.6K 0.01% 786
2022
Q4
$1.12M Buy
13,498
+5,038
+60% +$400K 0.01% 730
2022
Q3
$601K Buy
8,460
+4,652
+122% +$402K 0.01% 810
2022
Q2
$330K Sell
3,808
-6,136
-62% -$575K ﹤0.01% 891
2022
Q1
$1.08M Sell
9,944
-1,336
-12% -$138K 0.01% 764
2021
Q4
$1.46M Buy
11,280
+6,320
+127% +$775K 0.01% 766
2021
Q3
$601K Buy
+4,960
New +$604K ﹤0.01% 999

Other funds holding TECH

Rafferty Asset Management's TECH Position: Q1 2026 in Review

Rafferty Asset Management reduced its Bio-Techne (TECH) stake by 28% in Q1 2026, selling an estimated $281K and leaving 12,092 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Rafferty Asset Management first reported a position in TECH in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Rafferty Asset Management held 12,092 shares of Bio-Techne worth $632K as of Q1 2026.
  • Rafferty Asset Management sold 4,684 Bio-Techne shares in Q1 2026, an estimated $281K.
  • Bio-Techne made up ﹤0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #861 holding.
  • Rafferty Asset Management first reported a position in Bio-Techne in Q3 2021 and has held it in 19 quarters since.
  • Rafferty Asset Management's Bio-Techne position peaked at $1.48M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.